Amphastar Pharmaceuticals, Inc.
AMPH
$27.10
-$0.48-1.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.09% | 22.72% | -33.40% | -6.10% | 6.54% |
| Total Depreciation and Amortization | -2.90% | 6.79% | 3.70% | 1.60% | 2.04% |
| Total Amortization of Deferred Charges | 5.11% | 10.50% | 5.25% | -2.69% | -69.46% |
| Total Other Non-Cash Items | 9.61% | -43.00% | 166.95% | -234.71% | 96.55% |
| Change in Net Operating Assets | 164.76% | -10.84% | -94.58% | -17.24% | -184.85% |
| Cash from Operations | 47.74% | 1.47% | 20.86% | -51.60% | -13.24% |
| Capital Expenditure | 49.38% | 1.23% | 13.81% | 10.02% | -128.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -243.57% | -53.06% | 191.02% | -11.90% | -131.92% |
| Cash from Investing | -3,039.04% | -105.96% | 129.38% | -3.16% | 50.52% |
| Total Debt Issued | -95.83% | 151.46% | -66.27% | -48.80% | 38,132.00% |
| Total Debt Repaid | -18.92% | 2.63% | 66.96% | -180.49% | 99.49% |
| Issuance of Common Stock | -23.28% | -- | -- | -- | -- |
| Repurchase of Common Stock | 85.96% | -120.18% | 59.38% | -21.84% | -1,081.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.42% | 40.05% | -2,018.18% | 103.75% | -58,800.00% |
| Cash from Financing | 85.61% | -108.25% | 57.14% | -48.33% | -112.92% |
| Foreign Exchange rate Adjustments | -128.87% | 20.34% | 1,172.73% | 82.54% | -231.58% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 482.35% | -84.26% | 176.96% | -1,722.23% | 121.66% |